I Still Can't Believe Ambarella, Inc. Spent $100 Million on Research and Development
Ambarella's (NASDAQ: AMBA) sales footprint shrank last year, but the company got more aggressive on spending rather than less so. Operating costs jumped to 47% of sales from closer to 40% in each of the prior two fiscal years. That shift sent net profit plunging to 18% in 2016 from 25% in the prior year.
Source: Fool.com